Prolongation of survival of an allograft by inhibiting complement activity

Details for Australian Patent Application No. 2011236106 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Rother, Russell P.; Wang, Hao; Zhong, Zhen

Agent Shelston IP

Pub. Number AU-A-2011236106

Parent 2005244012

Filing date 18 October 2011

Wipo publication date 10 November 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61M 5/28 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way - Syringe ampoules or cartridges, i.e. ampoules or cartridges provided with a needle

Event Publications

3 November 2011 Complete Application Filed

10 November 2011 Application Open to Public Inspection

  Published as AU-A-2011236106

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011236107-Presenting media content items using geographical data

2011236105-Wireless Communication System Using Pilot Allocation, Method and Pilot Pattern Thereof